By Michele Maatouk
Date: Friday 05 Apr 2024
(Sharecast News) - Johnson & Johnson said on Friday that it has agreed to buy Shockwave Medical, which develops products for the treatment of cardiovascular disease, for $13.1bn.
Johnson & Johnson agrees to pay £13bn for Switze... | 28-Apr-2011 | The Independent |
S&N DRIFTS AS BID HOPES SLIP | 19-Apr-2011 | Express & Star |
J&J asks judge to dismiss kickback case | 08-Oct-2010 | Wall Street Journal |
Genzyme Again Rejects Sanofi’s Bid | 08-Oct-2010 | New York Times |
Johnson & Johnson buying vaccine maker Crucell | 07-Oct-2010 | USA Today |
Currency | US Dollars |
Share Price | $ 146.82 |
Change Today | $ 0.68 |
% Change | 0.47 % |
52 Week High | $174.48 |
52 Week Low | $144.45 |
Volume | 6,461,547 |
Shares Issued | 2,407.08m |
Market Cap | $353,407m |
RiskGrade | 87 |
Strong Buy | 5 |
Buy | 6 |
Neutral | 11 |
Sell | 0 |
Strong Sell | 0 |
Total | 22 |
Time | Volume / Share Price |
16:00 | 698,430 @ $146.82 |
16:00 | 456 @ $146.85 |
15:59 | 900 @ $146.83 |
15:59 | 100 @ $146.83 |
15:59 | 100 @ $146.83 |
You are here: research